The Timing of Early Antibiotics and Hospital Mortality in Sepsis
- PMID: 28345952
- PMCID: PMC5649973
- DOI: 10.1164/rccm.201609-1848OC
The Timing of Early Antibiotics and Hospital Mortality in Sepsis
Abstract
Rationale: Prior sepsis studies evaluating antibiotic timing have shown mixed results.
Objectives: To evaluate the association between antibiotic timing and mortality among patients with sepsis receiving antibiotics within 6 hours of emergency department registration.
Methods: Retrospective study of 35,000 randomly selected inpatients with sepsis treated at 21 emergency departments between 2010 and 2013 in Northern California. The primary exposure was antibiotics given within 6 hours of emergency department registration. The primary outcome was adjusted in-hospital mortality. We used detailed physiologic data to quantify severity of illness within 1 hour of registration and logistic regression to estimate the odds of hospital mortality based on antibiotic timing and patient factors.
Measurements and main results: The median time to antibiotic administration was 2.1 hours (interquartile range, 1.4-3.1 h). The adjusted odds ratio for hospital mortality based on each hour of delay in antibiotics after registration was 1.09 (95% confidence interval [CI], 1.05-1.13) for each elapsed hour between registration and antibiotic administration. The increase in absolute mortality associated with an hour's delay in antibiotic administration was 0.3% (95% CI, 0.01-0.6%; P = 0.04) for sepsis, 0.4% (95% CI, 0.1-0.8%; P = 0.02) for severe sepsis, and 1.8% (95% CI, 0.8-3.0%; P = 0.001) for shock.
Conclusions: In a large, contemporary, and multicenter sample of patients with sepsis in the emergency department, hourly delays in antibiotic administration were associated with increased odds of hospital mortality even among patients who received antibiotics within 6 hours. The odds increased within each sepsis severity strata, and the increased odds of mortality were greatest in septic shock.
Keywords: antibacterial agents; sepsis; septic shock.
Figures
Comment in
-
The Timing of Early Antibiotics and Hospital Mortality in Sepsis: Playing Devil's Advocate.Am J Respir Crit Care Med. 2017 Oct 1;196(7):934-935. doi: 10.1164/rccm.201703-0657LE. Am J Respir Crit Care Med. 2017. PMID: 28485616 No abstract available.
-
Reply: The Timing of Early Antibiotics and Hospital Mortality in Sepsis: Playing Devil's Advocate.Am J Respir Crit Care Med. 2017 Oct 1;196(7):935-936. doi: 10.1164/rccm.201704-0774LE. Am J Respir Crit Care Med. 2017. PMID: 28485627 No abstract available.
-
Antibiotics for Sepsis: Does Each Hour Really Count, or Is It Incestuous Amplification?Am J Respir Crit Care Med. 2017 Oct 1;196(7):800-802. doi: 10.1164/rccm.201703-0621ED. Am J Respir Crit Care Med. 2017. PMID: 28504905 No abstract available.
Similar articles
-
Delayed Second Dose Antibiotics for Patients Admitted From the Emergency Department With Sepsis: Prevalence, Risk Factors, and Outcomes.Crit Care Med. 2017 Jun;45(6):956-965. doi: 10.1097/CCM.0000000000002377. Crit Care Med. 2017. PMID: 28328652
-
The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.Crit Care Med. 2015 Sep;43(9):1907-15. doi: 10.1097/CCM.0000000000001142. Crit Care Med. 2015. PMID: 26121073 Free PMC article. Review.
-
Delays to Antibiotics in the Emergency Department and Risk of Mortality in Children With Sepsis.JAMA Netw Open. 2024 Jun 3;7(6):e2413955. doi: 10.1001/jamanetworkopen.2024.13955. JAMA Netw Open. 2024. PMID: 38837160 Free PMC article.
-
INITIAT-E.D.: Impact of timing of INITIation of Antibiotic Therapy on mortality of patients presenting to an Emergency Department with sepsis.Emerg Med Australas. 2015 Jun;27(3):196-201. doi: 10.1111/1742-6723.12394. Epub 2015 Apr 6. Emerg Med Australas. 2015. PMID: 25847048
-
Effect of delayed antibiotic use on mortality outcomes in patients with sepsis or septic shock: A systematic review and meta-analysis.Int Immunopharmacol. 2024 Mar 10;129:111616. doi: 10.1016/j.intimp.2024.111616. Epub 2024 Feb 3. Int Immunopharmacol. 2024. PMID: 38310764 Review.
Cited by
-
Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Fasciitis Mimicking Pseudogout in an Older Patient: A Diagnostic Challenge and Treatment Approach.Cureus. 2024 Oct 16;16(10):e71585. doi: 10.7759/cureus.71585. eCollection 2024 Oct. Cureus. 2024. PMID: 39559602 Free PMC article.
-
Exploring the value of hybrid capture-based next-generation sequencing technology in the suspected diagnosis of bloodstream infections.PeerJ. 2024 Nov 8;12:e18471. doi: 10.7717/peerj.18471. eCollection 2024. PeerJ. 2024. PMID: 39529632 Free PMC article.
-
Next-generation rapid phenotypic antimicrobial susceptibility testing.Nat Commun. 2024 Nov 9;15(1):9719. doi: 10.1038/s41467-024-53930-x. Nat Commun. 2024. PMID: 39521792 Free PMC article. Review.
-
Outcomes of Hospitalized Patients With Sepsis Before and After Implementation of a Sepsis Care Improvement Initiative at a Community Hospital.J Pharm Technol. 2024 Dec;40(6):263-268. doi: 10.1177/87551225241283193. Epub 2024 Sep 27. J Pharm Technol. 2024. PMID: 39507875
-
Clinical impact of the implementation of monocyte distribution width (MDW) measurement on time to anti-infective administration in sepsis patients in the emergency department: a before/after cohort study.Crit Care. 2024 Oct 27;28(1):346. doi: 10.1186/s13054-024-05141-5. Crit Care. 2024. PMID: 39465419 Free PMC article.
References
-
- Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637. - PubMed
-
- Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, Jaton K, Giulieri S, Delaloye J, Opal S, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15:581–614. - PubMed
-
- Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:2063. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical